Rsv vaccine, mrna Disease Interactions
There are 3 disease interactions with rsv vaccine, mrna.
RSV vaccine (applies to rsv vaccine, mrna) immunodeficiency
Moderate Potential Hazard, Moderate plausibility.
Immunocompromised individuals, including those receiving immunosuppressive therapy, may have a diminished immune response to the RSV vaccine.
RSV vaccine (applies to rsv vaccine, mrna) syncope
Moderate Potential Hazard, Moderate plausibility.
Syncope may occur in association with administration of injectable vaccines, including the RSV vaccine. Procedures should be in place to avoid injury from fainting, especially for patients who have previously fainted in association with an injection.
Vaccines (applies to rsv vaccine, mrna) IM injection
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Thrombocytopathy, Thrombocytopenia, Coagulation Defect
In patients with thrombocytopenia or coagulation disorders, IM injections may produce bleeding and hematomas. Patients with a platelet count less than 50,000/mm3 are at an increased risk. Caution is advised if the vaccine (e.g., plague vaccine; hepatitis A and B vaccines; aluminum-adsorbed DTaP, DTP, DT, or Td) must be administered IM. The risk of bleeding may be minimized by vaccination immediately after the administration of replacement factor, use of a 23-gauge (or smaller) needle, and immediate application of direct pressure to the vaccination site for at least 2 minutes.
Switch to professional interaction data
Rsv vaccine, mrna drug interactions
There are 302 drug interactions with rsv vaccine, mrna.
Report options
More about rsv vaccine, mrna
- rsv vaccine, mrna consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Arexvy
Arexvy is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Abrysvo
Abrysvo is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Beyfortus
Beyfortus is used to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in ...
mRESVIA
mRESVIA is a vaccine used to immunize adults aged 60 years and older against lower respiratory ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
Enflonsia
Enflonsia is an FDA-approved medication used to prevent respiratory syncytial virus (RSV) lower ...
Nirsevimab
Nirsevimab information from Drugs.com, includes Nirsevimab side effects, interactions and indications.
Rsv vaccine, pref a-pref b, recombinant
Respiratory Syncytial Virus (RSV) vaccines (Abrysvo, Arexvy, mResvia) are used to help reduce the ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
